NCT02572375View on ClinicalTrials.gov

Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

January 31, 2015

Conditions
Cough
Interventions
DRUG

Codeine Phosphate/Guaifenesin ER Tablet

Provide two Codeine Phosphate and Guaifenesin ER Tablet every 12 hours for 6 1/2 days.

DRUG

Codeine Phosphate/Guaifenesin IR Tablet

Provide one Codeine Phosphate and Guaifenesin IR Tablet every 4 hours for 6 1/2 days

Trial Locations (1)

11910

Pharmaceutical Research Unit, Amman

Sponsors

Lead Sponsor

Nexgen Pharma, Inc
All Listed Sponsors
collaborator

Pharmaceutical Research Unit, Jordan

OTHER

lead

Nexgen Pharma, Inc

INDUSTRY